The Group fights undeserved patent.
On August 20th, the Working Group on Intellectual Property (GTPI) of the Brazilian Network for the Integration of Peoples (REBRIP), integrated by the organizations ABIA, Conectas Human Rights, GAPA / SP, GAPA / RS, GRAB, Gestures – Seropositivity Communication and Gender, GIV, IDEC, and Fenaf RNP + / SLS, submitted pre-grant opposition to the technical examination of the patent application (PI0406760-6) of the drug Truvada ®, requested by Gilead Sciences Inc. Subsidies on technical examinations allow interested parties to present arguments that challenge a patent application. The organizations argued that the request should be denied for not meeting the requirements of patentability of the Industrial Property Law (9279/96).

